Home » Topics » Regulatory » Patents

Patents
RSS

Carbapenems in development at Sankyo

Jan. 7, 1999

Xanthine oxidase inhibitors for hyperuricemia, gout described by Yoshitomi in patent literature

Jan. 7, 1999

S-19777: novel ET antagonist of microbial origin

Jan. 7, 1999

Potent thrombin inhibitors with heterocyclic structure synthesized at Lilly

Jan. 7, 1999

ACAT-inhibitory urea derivatives claimed by Mitsubishi for lipid disorders

Jan. 7, 1999

Series of Na+/Ca2+ exchange inhibitors for ischemic disorders from Taisho

Jan. 7, 1999

Another series of heterocyclic thrombin inhibitors revealed by Lilly

Jan. 5, 1999

Novel compounds synthesized at BMS particularly useful for prevention of postsurgical adhesions

Jan. 5, 1999

Warner-Lambert claims new kappa-opioid agonists and their use

Jan. 4, 1999

Lilly's new 5-HT1D agonists claimed for CNS and bladder disorders

Jan. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...